ArticleCureus2025

Comparative Efficacy and Safety of Daily Versus Alternate-Day Dosing of Rosuvastatin in Diabetic Dyslipidemia: An Open-Label Clinical Trial.

Nalini Kumari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.